# 68Ga-C1 PET/ CT Imaging in Clear Cell Renal Cell Carcinoma

> **NCT06519760** · NA · RECRUITING · sponsor: **Peking University First Hospital** · enrollment: 200 (estimated)

## Conditions studied

- Carbonic Anhydrase IX
- PET-CT
- Clear Cell Renal Cell Carcinoma

## Interventions

- **DRUG:** 68Ga-C1

## Key facts

- **NCT ID:** NCT06519760
- **Lead sponsor:** Peking University First Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-30
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-12-31
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2024-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06519760

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06519760, "68Ga-C1 PET/ CT Imaging in Clear Cell Renal Cell Carcinoma". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06519760. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*